trending Market Intelligence /marketintelligence/en/news-insights/trending/9ukfIdKVG4_GiAMx3kTv8A2 content esgSubNav
In This List

Intellia Therapeutics names CFO

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Intellia Therapeutics names CFO

Intellia Therapeutics Inc. named Graeme Bell CFO, succeeding Sapna Srivastava, who will be moving to a senior advisory role within the company.

Bell previously served as CFO at Anacor Pharmaceuticals Inc.